FindTrial
Sign In

Impact of meditation on Telomere length of cancer patients on chemotherapy

Impact of meditation on Telomere length of cancer patients on chemotherapy - nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107667
Enrollment
60
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Heartfulness CARE support program: Heartfulness meditation intervention includes 15-minute morning relaxation with visualization and 15-minute evening rejuvenation practices, supported

Sponsors

Madras Medical College Rajiv Gandhi Government General Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients of breast cancer, 3 to 6 months of post diagnosis and on chemotherapy with performance status of 0, 1, 2 of Eastern Cooperative Oncology Group (ECOG)/WHO system

Exclusion criteria

Exclusion criteria: Patients with severe psychiatric disorders, existing meditation practices, and health conditions affecting telomere length independently (e.g., severe autoimmune diseases)

Design outcomes

Primary

MeasureTime frame
To estimate the impact of meditation on the telomere length of cancer patients on chemotherapy.Timepoint: one year—

Secondary

MeasureTime frame
To measure the effect of meditation on psychological wellbeing among study participants by perceived stress level questionnaire. Timepoint: one year—

Countries

India

Contacts

Public ContactUsha Krishnan

Madras Medical College

ushakrishnan72@gmail.com9884824617

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026